newsfilter
← Latest News
GlobeNewswire·

OKYO Pharma to Present at BIO-Europe 2025 in Vienna

LONDON and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a